Effects of Tetracyclines on Bone Metabolism

Effects of Tetracyclines on Bone Metabolism
复制标题

四环素类药物对骨代谢的影响

DOI:
10.1177/08959374980120012101
复制
发表时间:
1998
影响因子:
--
通讯作者:
B. Rifkin
B. Rifkin
中科院分区:
--
文献类型:
--
作者:
A. Vernillo;B. Rifkin

文献摘要

参考文献

被引文献

相似文献

四环素类抗生素及其非抗菌、化学修饰的类似物具有抗骨吸收的特性,在医学和牙科领域具有巨大的治疗潜力。与过度的哺乳动物胶原酶(基质金属蛋白酶)活性和胶原分解相关的骨破坏性疾病包括恶性肿瘤、关节炎和牙周炎。然而,除了TC的显著抗基质金属蛋白酶作用之外,TC/CMT也是破骨细胞功能的有效抑制剂(即,抗再吸收的)。因此,TC可以影响破骨细胞功能的几个参数,并因此通过(1)改变细胞内钙浓度并与推定的钙受体相互作用;(2)减少皱褶边缘区域;(3)减少酸产生;(4)减少溶酶体半胱氨酸蛋白酶的分泌来抑制骨吸收(组织蛋白酶);(5)通过影响足体诱导细胞收缩;(6)抑制破骨细胞明胶酶活性;(7)选择性抑制破骨细胞个体发生或发育;和(8)诱导破骨细胞的凋亡或程序性细胞死亡。TC/CMT作为抗再吸收药物,可能与双膦酸盐类似,主要影响破骨细胞功能。
The anti-resorptive properties of tetracyclines (TCs) and their non-antimicrobial, chemically modified analogues (CMTs) have enormous therapeutic potential in medicine and dentistry. Osseous destructive diseases associated with excessive mammalian collagenase (matrix metalloproteinase) activity and collagen breakdown include malignancy, arthritis, and periodontitis. However, apart from the significant antimatrix metalloproteinase effects of TCs, TCs/CMTs are also potent inhibitors of osteoclast function (i.e., anti-resorptive). Thus, TCs can affect several parameters of osteoclast function and consequently inhibit bone resorption by (1) altering intracellular calcium concentration and interacting with the putative calcium receptor; (2) decreasing ruffled border area; (3) diminishing acid production; (4) diminishing the secretion of lysosomal cysteine proteinases (cathepsins); (5) inducing cell retraction by affecting podosomes; (6) inhibiting osteoclast gelatinase activity; (7) selectively inhibiting osteoclast ontogeny or development; and (8) inducing apoptosis or programmed cell death of osteoclasts. TCs/CMTs, as anti-resorptive drugs, may act similarly to bisphosphonates and primarily affect osteoclast function.
DOI: 10.1172/jci118197
发表时间: 1995-09
期刊: The Journal of clinical investigation
影响因子: --
作者:
M. Zaidi;V. Shankar;R. Tunwell;O. Adebanjo;J. Mackrill;M. Pazianas;D. O'Connell;B. Simon;B. Rifkin;A. Venkitaraman
通讯作者: M. Zaidi;V. Shankar;R. Tunwell;O. Adebanjo;J. Mackrill;M. Pazianas;D. O'Connell;B. Simon;B. Rifkin;A. Venkitaraman
分离的破骨细胞中的组织蛋白酶 B 和 L 活性。
DOI: 10.1016/0006-291x(91)91334-9
发表时间: 1991
影响因子: 3.1
作者:
Rifkin,BR;Vernillo,AT;Kleckner,AP;Auszmann,JM;Rosenberg,LR;Zimmerman,M
通讯作者: Zimmerman,M
DOI: 10.1111/j.1600-0765.1983.tb00388.x
发表时间: 1983-01-01
影响因子: 3.5
作者:
GOLUB, LM;LEE, HM;RAMAMURTHY, NS
通讯作者: RAMAMURTHY, NS
DOI: 10.1111/j.1600-0765.1982.tb02046.x
发表时间: 1982
影响因子: 3.5
作者:
Sakamoto,S;Sakamoto,M
通讯作者: Sakamoto,M
分离的破骨细胞中的碳酸酐酶活性。
DOI: 10.1016/0221-8747(83)90048-6
发表时间: 1983
期刊: Metabolic bone disease & related research
影响因子: --
作者:
Gay,CV;Ito,MB;Schraer,H
通讯作者: Schraer,H